Aeterna Zentaris
AEZS
#10808
Rank
A$24.89 M
Marketcap
A$8.13
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): A-$3.11

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is A-$2.91. In 2022 the company made an earnings per share (EPS) of A-$6.65 a decrease over its 2021 EPS that were of A-$2.59.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$3.11
2022A-$6.65157.14%
2021A-$2.59-41.48%
2020A-$4.42-64.46%
2019A-$12.44-240%
2018A$8.88-122.32%
2017A-$39.80-53.53%
2016A-$85.64-86.71%
2015A-$644.60-35.21%
2014A-$994.98-216.67%
2013A$852.84-123.3%
2012A-$3,660-40.8%
2011A-$6,183-6.45%
2010A-$6,609-27.91%
2009A-$9,168-61.61%
2008A-$23,87983.61%
2007A-$13,006-195.31%
2006A$13,645178.26%
2005A$4,904-330%
2004A-$2,132-80.05%
2003A-$10,68717.78%
2002A-$9,074515.93%
2001A-$1,473-68.6%
2000A-$4,692119.62%
1999A-$2,136-3.63%
1998A-$2,217

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$9.47-425.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$2.70-192.88%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$6.45-321.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.51-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$5.00-271.80%๐Ÿ‡บ๐Ÿ‡ธ USA